Work

AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice

Year: 2011

Type: article

Source: Cell Metabolism

DOI: 10.1016/j.cmet.2011.03.009

Authors: Yu Li, Shanqin Xu, Maria M. Mihaylova, Bin Zheng, Xiuyun Hou, Bingbing Jiang, Ogyi Park, Zhijun Luo, Etienne Lefai, John Y.-J. Shyy, Bin Gao, Michel Wierzbicki, Tony J. Verbeuren, Reuben J. Shaw, Richard A. Cohen, Mengwei Zang

Institutions: Boston University, Salk Institute for Biological Studies, Howard Hughes Medical Institute, Columbia University, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Inserm, Laboratoire de recherche en cardiovasculaire, métabolisme, diabétologie et nutrition, Institut National des Sciences Appliquées de Lyon, University of California, Riverside, University of California San Diego, Servier (France), Institut de Recherches Internationales Servier (France)

Language: English

Topic: Metabolism, Diabetes, and Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institute on Alcohol Abuse and Alcoholism, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1130182629, G2019090012, G2607907475, G2940777275, Vanderbilt Mouse Metabolic Phenotyping Center, AMPK Endothelial Cell Dysfunction and the Metabolic Syndrome (PROGRAM PROJECT)

OpenAlex ID: W2011574523

FWCI: 27.27

Cites: 50

Cited by: 1,786

Related to: 10